Stelzer Laurie (CIK 0001644348)

Latest company ownership

Shares held
6,875
Last filed at
Jun 16, 2016
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 22, 2020 Feb 24, 2020 HALOZYME THERAPEUTICS, INC. CFO Sell 42.5 -4,508 -3.45% ✗ $98.4K
Feb 14, 2020 Feb 18, 2020 HALOZYME THERAPEUTICS, INC. CFO Sell 42.5 -2,700 -2.21% ✗ $57K
Feb 12, 2020 Feb 13, 2020 HALOZYME THERAPEUTICS, INC. CFO Sell 42.5 -3,894 -3.30% ✗ $77.9K
Feb 3, 2020 Feb 4, 2020 HALOZYME THERAPEUTICS, INC. CFO Sell 42.5 -8,275 -7.19% ✗ $159K
Jun 15, 2019 Jun 17, 2019 HALOZYME THERAPEUTICS, INC. CFO Sell 42.5 -3,408 -3.57% ✗ $53.6K
Feb 22, 2019 Feb 22, 2019 HALOZYME THERAPEUTICS, INC. CFO Sell 42.5 -3,939 -4.26% ✗ $66.2K
Feb 14, 2019 Feb 15, 2019 HALOZYME THERAPEUTICS, INC. CFO Sell 46.3 -2,700 -3.22% ✗ $44.7K
Feb 3, 2019 Feb 5, 2019 HALOZYME THERAPEUTICS, INC. CFO Sell 42.5 -8,317 -9.87% ✗ $134.1K
Jun 15, 2018 Jun 18, 2018 HALOZYME THERAPEUTICS, INC. CFO Sell 42.5 -3,254 -5.05% ✗ $61.9K
Feb 22, 2018 Feb 23, 2018 HALOZYME THERAPEUTICS, INC. CFO Sell 42.5 -3,939 -6.41% ✗ $75.9K
Feb 3, 2018 Feb 5, 2018 HALOZYME THERAPEUTICS, INC. CFO Sell 42.5 -8,265 -14.17% ✗ $151.8K
Jun 15, 2017 Jun 16, 2017 HALOZYME THERAPEUTICS, INC. CFO Sell 46.3 -2,583 -6.84% ✗ $33.7K
Feb 3, 2017 Feb 6, 2017 HALOZYME THERAPEUTICS, INC. CFO Sell 42.5 -9,085 -22.72% ✗ $111.4K
Aug 20, 2015 Aug 26, 2015 HALOZYME THERAPEUTICS, INC. CFO Buy 95.0 +10,000 100.00% ✗ $172.4K
Aug 20, 2015 Aug 24, 2015 HALOZYME THERAPEUTICS, INC. CFO Buy 95.0 +10,000 100.00% ✗ $172.4K